These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9618803)

  • 1. Insulin-like growth factor-I and -II in human benign prostatic hyperplasia: relationship with binding proteins 2 and 3 and androgens.
    Monti S; Di Silverio F; Lanzara S; Varasano P; Martini C; Tosti-Croce C; Sciarra F
    Steroids; 1998; 63(5-6):362-6. PubMed ID: 9618803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens.
    Monti S; Di Silverio F; Iraci R; Martini C; Lanzara S; Falasca P; Poggi M; Stigliano A; Sciarra F; Toscano V
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1700-6. PubMed ID: 11297606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DHT and testosterone, but not DHEA or E2, differentially modulate IGF-I, IGFBP-2, and IGFBP-3 in human prostatic stromal cells.
    Le H; Arnold JT; McFann KK; Blackman MR
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E952-60. PubMed ID: 16368782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutritional regulation of circulating insulin-like growth factors (IGFs) and their binding proteins in the ovine fetus.
    Lee WH; Gaylord TD; Bowsher RR; Hlaing M; Moorehead H; Liechty EA
    Endocr J; 1997 Feb; 44(1):163-73. PubMed ID: 9152630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretion of insulin-like growth factors and their binding proteins by human normal and hyperplastic prostatic cells in primary culture.
    Boudon C; Rodier G; Lechevallier E; Mottet N; Barenton B; Sultan C
    J Clin Endocrinol Metab; 1996 Feb; 81(2):612-7. PubMed ID: 8636277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen concentrations and their receptors in the periurethral region are higher than those of the subcapsular zone in benign prostatic hyperplasia (BPH).
    Monti S; Di Silverio F; Toscano V; Martini C; Lanzara S; Varasano PA; Sciarra F
    J Androl; 1998; 19(4):428-33. PubMed ID: 9733145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factors and insulin-like growth factor binding proteins in androgen-dominant ovarian follicles from testosterone-treated female-to-male trans-sexuals.
    Yap OW; van Dessel HJ; Chandrasekher YA; Fauser BC; Giudice LC
    Fertil Steril; 1997 Aug; 68(2):252-8. PubMed ID: 9240252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular distribution and ontogeny of insulin-like growth factors (IGFs) and IGF binding protein messenger RNAs and peptides in developing rat pancreas.
    Hill DJ; Hogg J; Petrik J; Arany E; Han VK
    J Endocrinol; 1999 Feb; 160(2):305-17. PubMed ID: 9924201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia.
    Di Silverio F; Monti S; Sciarra A; Varasano PA; Martini C; Lanzara S; D'Eramo G; Di Nicola S; Toscano V
    Prostate; 1998 Oct; 37(2):77-83. PubMed ID: 9759701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth regulation of prostatic stromal cells by prostate-specific antigen.
    Sutkowski DM; Goode RL; Baniel J; Teater C; Cohen P; McNulty AM; Hsiung HM; Becker GW; Neubauer BL
    J Natl Cancer Inst; 1999 Oct; 91(19):1663-9. PubMed ID: 10511594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
    Arnold JT; Le H; McFann KK; Blackman MR
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum and follicular fluid levels of insulin-like growth factor I (IGF-I), IGF-II, and IGF-binding protein-1 and -3 during the normal menstrual cycle.
    Thierry van Dessel HJ; Chandrasekher Y; Yap OW; Lee PD; Hintz RL; Faessen GH; Braat DD; Fauser BC; Giudice LC
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1224-31. PubMed ID: 8772603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between oestradiol-17 beta, testosterone, dihydrotestosterone and 5 alpha-androstane-3 alpha, 27 beta-diol in human benign hypertrophy and carcinoma of the prostate.
    Ghanadian R; Puah CM
    J Endocrinol; 1981 Feb; 88(2):255-62. PubMed ID: 6162906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgens and estrogens: their interaction with stroma and epithelium of human benign prostatic hyperplasia and normal prostate.
    Krieg M; Bartsch W; Thomsen M; Voigt KD
    J Steroid Biochem; 1983 Jul; 19(1A):155-61. PubMed ID: 6193338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ontogeny of insulin-like growth factors (IGF-I and IGF-II) and IGF-binding proteins in porcine serum during fetal and postnatal development.
    Lee CY; Bazer FW; Etherton TD; Simmen FA
    Endocrinology; 1991 May; 128(5):2336-44. PubMed ID: 1708333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ; Baxter RC
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):333-42. PubMed ID: 9156044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia.
    Cohen P; Peehl DM; Baker B; Liu F; Hintz RL; Rosenfeld RG
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1410-5. PubMed ID: 7525636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostatic involution in men taking finasteride is associated with elevated levels of insulin-like growth factor-binding proteins (IGFBPs)-2, -4, and -5 .
    Thomas LN; Wright AS; Lazier CB; Cohen P; Rittmaster RS
    Prostate; 2000 Feb; 42(3):203-10. PubMed ID: 10639191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relaxin increases insulin-like growth factors (IGFs) and IGF-binding proteins of the pig uterus in vivo.
    Ohleth KM; Lenhart JA; Ryan PL; Radecki SV; Bagnell CA
    Endocrinology; 1997 Sep; 138(9):3652-8. PubMed ID: 9275049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factors and risk of benign prostatic hyperplasia.
    Chokkalingam AP; Gao YT; Deng J; Stanczyk FZ; Sesterhenn IA; Mostofi FK; Fraumeni JF; Hsing AW
    Prostate; 2002 Jul; 52(2):98-105. PubMed ID: 12111701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.